A Lymphoedema prevention tool

Secondary Lymphoedema is the most common post treatment complication for cancer patients. Both men and women are at risk of developing lymphoedema if they have had surgery, radiation treatment or Taxane-based chemotherapy.

The SOZO uses new technology, which aids in early detection of lymphoedema. At risk patients receive a baseline measurement, preferably before treatment and then after treatment, detecting fluid build up in an at-risk limb, compared to a healthy limb.

Taking only 30seconds to measure, the SOZO uses noninvasive bioimpedance spectroscopy (BIS), which detects fluid changes as small as 36ml (2.4 tablespoons).

Recently published interim results from the PREVENT Trial showed that this early detection combined with at-home intervention using standard compression therapy can reduce the progression of lymphoedema by 95%. (taken from the impedimed website)